Literature DB >> 3924084

Effect of alfentanil anaesthesia on the adrenocortical and hyperglycaemic response to abdominal surgery.

I W Møller, T Krantz, E Wandall, H Kehlet.   

Abstract

Plasma concentrations of cortisol and glucose were measured from before to 9 h after skin incision in 24 patients undergoing abdominal hysterectomy. The patients were randomly allocated to receive either high-dose alfentanil anaesthesia (150 micrograms kg-1 initially, followed by continuous infusion at a rate of 3 micrograms kg-1 min-1) or neurolept anaesthesia (droperidol 0.25 mg kg-1 plus fentanyl 5 micrograms kg-1 initially, followed by intermittent incremental doses of fentanyl 50 micrograms). The intraoperative and initial postoperative increases in plasma cortisol and glucose concentrations were inhibited (P less than 0.05) by alfentanil but, later in the postoperative period, both groups showed identical increases in cortisol and glucose concentrations. Mean arterial pressure and heart rate were more stable in the alfentanil group. The concept of "stress-free" anaesthesia during high-dose opiate administration seems to be valid during operation and for the initial 1-3 h into the postoperative period.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3924084     DOI: 10.1093/bja/57.6.591

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  3 in total

1.  The effect of combined epidural and light general anesthesia on stress hormones in open heart surgery patients.

Authors:  B K Chae; H W Lee; K Sun; Y H Choi; H M Kim
Journal:  Surg Today       Date:  1998       Impact factor: 2.549

Review 2.  Alfentanil infusions in patients requiring intensive care.

Authors:  A Bodenham; G R Park
Journal:  Clin Pharmacokinet       Date:  1988-10       Impact factor: 6.447

3.  Alfentanil infusions on the intensive therapy unit.

Authors:  M E Sinclair; J W Sear; R J Summerfield; A Fisher
Journal:  Intensive Care Med       Date:  1988       Impact factor: 17.440

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.